NEPH
Nephros, Inc.
OTC BB
People also watch:BIELADLSNRIFFIGNTHEB
0.26-0.01 (-5.52%)
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Prev Close0.27
Open0.26
Bid0.00 x
Ask0.00 x
52wk Range0.20 - 0.76
Day's Range0.26 - 0.28
Volume13,536
Avg Vol (3m)13,888
As of 12:16 PM EDT. Market closed.
  • Nephros, Inc. :NEPH-US: Earnings Analysis: Q1, 2016 By the Numbers
    Capital Cube2 months ago

    Nephros, Inc. :NEPH-US: Earnings Analysis: Q1, 2016 By the Numbers

    Click here to see latest analysisNephros, Inc. reports financial results for the quarter ended March 31, 2016.We analyze the earnings along side the following peers of Nephros, Inc. – Rockwell Medical, Inc., Misonix, Inc., Boston Scientific Corporation, Thermo Fisher Scientific Inc., Baxter International Inc., NxStage Medical, Inc. and Danaher Corporation (RMTI-US, MSON-US, BSX-US, TMO-US, BAX-US, […] (Read more...) The post Nephros, Inc. :NEPH-US: Earnings Analysis: Q1, 2016 By the Numbers appeared first on CapitalCube.

  • Nephros, Inc. Earnings Q3, 2015
    Capital Cube8 months ago

    Nephros, Inc. Earnings Q3, 2015

    Click here to see latest analysisNephros, Inc. reports financial results for the quarter ended September 30, 2015.We analyze the earnings along side the following peers of Nephros, Inc. – Rockwell Medical, Inc., Misonix, Inc., Boston Scientific Corporation, Thermo Fisher Scientific Inc., Baxter International Inc., NxStage Medical, Inc., Danaher Corporation and Mesa Laboratories, Inc. (RMTI-US, MSON-US, […] (Read more...) The post Nephros, Inc. Earnings Q3, 2015 appeared first on CapitalCube.